Introduction
A brief overview of the neurodegenerative dementias Dementia or the substantial loss of intellectual abilities such as memory capacity, severe enough to interfere with social or occupational functioning, is one of world's most devastating and burdensome health conditions. It is estimated that 24.3 million people have dementia today, with 4.6 million new cases annually [1] . Moreover, as a result of our aging population, the number of people affected with dementia is expected to double every 20 years. Alzheimer's disease (AD) is by far the most frequent form of dementia comprising 50-70% of all cases and affecting 40% of individuals older than 85 years [2] . A definite diagnosis of AD requires the presence of extraneuronal b-amyloid plaques and intraneuronal neurofibrillary tangles composed of hyperphosphorylated tau in the degenerating brain [3] . Dementia is also present as a common clinical feature in a host of related neurodegenerative diseases (Table 1) . Lewy-body disease (LBD) is considered the second commonest cause of dementia in patients older than 65 years [4] ; however, in presenile dementia patients frontotemporal lobar degeneration (FTLD) is the second most common diagnosis after AD [5] . FTLD patients are clinically characterized by personality changes and disinhibited behavior, often combined with a gradual and progressive language dysfunction. Memory impairment is typically preserved in the early phase of disease, which distinguishes them from patients with AD. Pathologically, 40% of FTLD patients present with neuronal and/or glial tau aggregates (FTLDtau), whereas the majority of FTLD patients show ubiquitinimmunoreactive cytoplasmic (NCI) and intranuclear inclusions (NII) historically referred to as FTLD-U (FTLD with ubiquitin-positive inclusions). Up to four subtypes of FTLD-U have been delineated that are based on the distribution of NCIs, dystrophic neurites and the presence of NIIs [6, 7] . More recently, it was shown that hyperphosphorylated and C-terminal truncated fragments of the nuclear protein TAR DNA binding protein 43 (TDP-43) were the main component of the pathological inclusions in FTLD-U, and the term FTLD-TDP was introduced [8] . Despite welldefined clinical diagnostic criteria, the differential diagnosis of neurodegenerative dementias is often challenging. This is particularly true for AD and FTLD, which have been suggested to belong to a spectrum of neurodegenerative diseases [9] .
In recent years, substantial progress has been made in understanding the molecular genetics and underlying pathological substrates of AD and FTLD, which will be the focus of the current review. For additional information on LBD and other Parkinson-related dementias we refer to recent reviews by Bonifati et al. [10] and Ferman and Boeve [11] .
Genetic aspects of AD and FTLD AD is a genetically complex and heterogeneous disorder [12] . Less than 10% of AD patients have an early-onset of disease (before the age of 65 years), and 60% of these patients are familial, with an autosomal dominant inheritance of the disease in 13% of patients [13] . In autosomal dominant AD families, rare mutations in the amyloid
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Nonsense-mediated decay (NMD): nonsense mediated decay is a eukaryotic quality control mechanism that selectively degrades mRNA species harboring premature termination (nonsense) codons to prevent the expression of truncated or erroneous proteins. Haploinsuffiency: Haploinsufficiency refers to a situation where an individual who is heterozygous for a certain gene mutation is clinically affected because 50% of the level of gene function is not sufficient to assure normal function. Cerebral amyloid angiopathy (CAA): cerebral amyloid angiopathy, also known as congophilic angiopathy, is a disease of small blood vessels in the brain, in which deposits of b-amyloid in the blood vessel walls could lead to stroke, brain hemorrhage or dementia. CAA is a common feature in AD patients with APP duplications and APP missense mutations in the a-secretase cleavage site. Linkage disequilibrium: in population genetics, the term linkage disequilibrium refers to a situation where a particular allele at one locus is found together on the same chromosome with a specific allele at a second locus, more often than expected if the loci were segregating independently in the population. Corresponding author: Rademakers, R. (rademakers.rosa@mayo.edu).
